Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.

Saved in:
Bibliographic Details
Title: Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.
Authors: Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Anand IS; VA Medical Center and University of Minnesota, Minneapolis, Minnesota., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Lefkowitz MP; Novartis, East Hanover, New Jersey, USA., Maggioni AP; ANMCO Research Center, Florence, Italy., Martinez FA; University of Cordoba, Cordoba, Argentina., Redfield MM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Quebec, Canada., Van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zannad F; Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, University Hospital, University of Lorraine, Nancy, France., Zile MR; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Source: JACC. Heart failure [JACC Heart Fail] 2025 Jun; Vol. 13 (6), pp. 927-939. Date of Electronic Publication: 2025 Mar 12.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-1787
DOI:10.1016/j.jchf.2024.12.010